// App-Quantinova.ai

: Novel Snake Venom Derived Hemocoagulase Reverses Anticoagulant Effect of Factor Xa Inhibitors, Restores Hemostatic Clot Formation, and Limits Bleeding in Vitro and In Vivo

Researchers

Presenter

  • Nicole Rhoads

Principal Investigators

  • Michael Wong

  • Benjamin Li

  • Michael Holinstat

  • Raymond Adili

Medical Centers

  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI

Locations

  • Hong Kong

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Hemostatic Solution

  • apixaban

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A